Vaso Corporation (VASO) Return on Investment ROI from the second quarter of 2026 to second quarter of 2025 and for the year 2026, average high and low, overall ranking from Jun 30 2026 to Jun 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Vaso Corporation  (VASO)


Vaso's ROI from its second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Vaso's ROI in the second quarter of 2026?
Vaso Corporation achieved a return on average invested assets (ROI) of 7.04 % in its second quarter of 2026, this is above VASO's average return on investment of 3.15%.
Vaso Corporation invested over the 12 months ending in its second quarter of 2026 $35 million

ROI has improved compared to 6.09% in the first quarter of 2026, due to net income growth.

Within the Healthcare sector 37 other companies had a higher return on investment. While Return on investment, overall ranking has progressed in the Jun 30 2026 quarter, so far to 1735, from total ROI ranking in the first quarter of 2026 at 2449.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Investment Change TTM 33.31 % 8.16 % -5.28 % -21.08 % -30.34 %
Y / Y Net Income Change TTM - 67.49 % -26.13 % - -
Investment (TTM) in Millions 53 29 32 28 27
Return On Investment (TTM) 7.04 % 6.09 % 5.53 % 9.49 % -1.14 %
VASO's Overall Ranking # 1735 # 2449 # 1107 # 2281 #
Seq. Investment Change TTM 22.99 % 1.72 % 4.04 % 2.42 % -0.21 %
Seq. Net Income Change TTM 42.17 % 11.98 % -39.4 % - -
Net Income (TTM) in Millions 2 2 2 3 0

VASO Company Profile >> Back to VASO Roi Comparisons >> See Annual VASO Return On Investment



Return On Investment VASO's Ranking
Within: No.
Industry # 11
Sector # 38
Overall # 1735

Return On Investment Statistics
High Average Low
43.55 %
3.15 %
-37.6 %
(Dec 31 2022)   (Jun 30 2019)







Financial Statements
Vaso's II. Quarter Investments $ 53 Millions VASO's Balance sheet
Vaso's II. Quarter Income $ 1 Millions Quarterly VASO's Income Statement
VASO's Income by Division See VASO's Income by Division


VASO Annual Return On Investment (Dec 31 2025)
2025		 (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021
Total Investments in Millions 32 28 46 39 21
Y / Y Investment Growth 15.9 % -39.92 % 19.6 % 85.44 % 15.75 %
Net Income in Millions 2 1 5 12 0
Y / Y Net Income Growth 64.98 % -80.21 % -59.53 % - -
Annual Return On Investment 4.89 % 3.43 % 10.42 % 30.8 % 0 %


Annual Roi Comment
In the fiscal year 2025 ROI improved to 4.89 % compared to the prior year, due to net income growth.

Definition and Formula of Return on Investment

Other ROI Ratios
Medical Equipment & Supplies Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
VASO's Roi Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for VASO's Competitors
Subscribers only: Roi for Vaso's Suppliers
Subscribers only: Return On Investment for VASO's Customers

Other Ratios
VASO's Roa VASO's Inventory Turnover Ratio VASO's Growth Rates VASO's Dividend Statistics
VASO's Profitability Ratios VASO's Asset Turnover Ratio VASO's Dividend Growth
VASO's Roe VASO's Valuation Ratios VASO's Financial Strength Ratios VASO's Dividend Payout Ratio



Companies with similar Return On Investment at Jun 30 2026, within Healthcare Sector ROI
Krystal Biotech Inc   19.16 %
Carlisle Companies Incorporated  18.88 %
Neurocrine Biosciences Inc   17.51 %
Intuitive Surgical Inc   17.11 %
Theravance Biopharma inc   17.10 %
Standard Biotools Inc   16.38 %
Inspire Medical Systems inc   16.34 %
Aveanna Healthcare Holdings Inc   16.32 %
Harmony Biosciences Holdings inc   15.85 %
Entera Bio Ltd   15.84 %
Nephros Inc   15.31 %
West Pharmaceutical Services Inc   15.29 %
Progyny Inc   15.25 %
Biolife Solutions Inc   14.83 %
Sbc Medical Group Holdings Incorporated  14.78 %
Spero Therapeutics Inc   14.54 %
Insulet Corporation  14.30 %
Alpha Pro Tech Ltd   13.80 %
Bristol myers Squibb Company  13.58 %
Transmedics Group Inc   13.46 %
Strata Critical Medical Inc   13.34 %
Johnson and Johnson  13.30 %
Amgen Inc   13.08 %
Medinotec Inc   13.06 %
Lantheus Holdings Inc   13.02 %
Msa Safety Inc  13.02 %
Universal Health Services Inc   12.43 %
Ufp Technologies Inc   12.12 %
Solventum Corporation  11.98 %
Ligand Pharmaceuticals Incorporated  11.93 %

Date modified: 2026-08-17T07:34:22+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.